
    
      Primary Objective

      The primary objective of the study is to provide access to LJPC-501 for distributive shock
      patients who remain hypotensive despite receiving fluid and vasopressor therapy.

      Secondary Objective

      The secondary objective of the study is to assess the safety of LJPC-501.
    
  